0238-DST-High Content Screening System with Confocal and Widefield Modalities

MEDICINES DISCOVERY CATAPULTcontractContracts FinderRef MEDDISC001-DN640362-94376882closed
View buyer

Estimated value

£750k

Awarded value

Suppliers

0

Lots

1

0 awarded

Published

31 Oct 2022

Deadline 21 Nov 2022

Description

The Advanced Technologies team at the Medicines Discovery Catapult (MDC) is looking to expand its current advanced microscopy facility to support both our own growing needs and provide the UK SME community access to advanced molecular and cellular imaging. MDC is aiming purchase a confocal High Content Screening (HCS) instrument based on an automated well-plate inverted microscope, together with confocal and widefield functionalities. It is crucial for the HCS system to be flexible and provide fast and high-resolution imaging of a wide range of experiments. The instrument should be configured to enable the use of different sample formats (2D and 3D cell models, tissue sections, fixed and live-cell) and experimental types (drug dose responses, live-cell kinetic studies, phenotypic screening, RNA scope), using a large variety of well-plate formats and a wide range of fluorophores. In addition, the HCS instrument must be supplied with a high-end solution for high content image analysis, visualization and handling. For more information, please follow this link - https://procontract.due-north.com/Advert?advertId=3e1c3152-f658-ed11-811b-9f38301b3091

Scope

Reference
MEDDISC001-DN640362-94376882
Total value
£750,000 excluding VAT
Commercial tool
Standalone contract
Contract dates
03 Jan 2023 to 02 Jan 2027
CPV classifications
38000000

Submission & procedure

Submission deadline
21 Nov 2022, 12:00 pm